EMBO ReportsImmunologyPeer-reviewed journal article
Effector T cells in poorly perfused tumor regions exhibit a distinct signature of augmented IFN response and reduced PD-1 expression
Marta Riera-BorrulliD, Víctor Cerdán PorquerasiD, Sonia Tejedor VaqueroiD, Claudia Tomaselli GonzáleziD, Mauricio GuzmániD, Donata MartinuzziiD, Diego Ceacero‐HerasiD, Andrea CeruttiiD, Jose F. AramburuiD, Cristina López‐RodrígueziD
Abstract
Effector T lymphocytes are avid glucose consumers, but can function in the nutrient-poor environments of tumors. However, availability of blood-delivered nutrients throughout the tumor is not homogeneous, and how this affects effector T cells is not well known. Here we have isolated tumor-infiltrating T lymphocytes (TILs) from mouse solid tumors by their capacity to capture blood-transported probes, and compared them with glucose-restricted T cells. Glucose restriction in vitro arrested cell proliferation but reduced only moderately the induction of hallmark glucose-dependent cytokines interferon gamma (IFN{gamma}) and IL-17. In vivo, effector TILs with reduced access to blood had characteristics of glucose-restricted cells, such as reduced expression of IFN{gamma} and genes associated with cell proliferation. However, they expressed more CXCR3, which identifies effective antitumor T lymphocytes, showed an enhanced IFN response signature, and had reduced expression of surface PD-1. We also identified genes regulated by the enzyme ACSS2, which allows TILs to sustain gene expression in glucose-poor environments. Thus, effector T lymphocytes infiltrating tumors express different gene signatures in regions with different accessibility to blood, and can maintain specific glucose-dependent responses even in poorly perfused tumor regions. Our results can help better understand nutrient-dependent TIL heterogeneity in changing tumor microenvironments. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=102 SRC="FIGDIR/small/601540v1_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@115d6beorg.highwire.dtl.DTLVardef@c56904org.highwire.dtl.DTLVardef@71b324org.highwire.dtl.DTLVardef@a804d0_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: mouse
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 32th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Inosine is an alternative carbon supply that supports effector T cell proliferation and anti-tumor function under glucose restriction
T. Wang, J. R. Gnanaprakasam, … R. Wang·bioRxiv·Sep 14, 2019
- GLUT5 armouring enhances adoptive T cell therapy anti-tumour activity under glucose-limiting conditions
Robert Lee Page II, Olivier Martínez, … Esperanza Perucha·Immunotherapy AdvancesPeer-reviewed·Dec 30, 2024
- Cell Programmed Nutrient Partitioning in the Tumor Microenvironment
B. I. Reinfeld, M. Z. Madden, … W. K. Rathmell·bioRxiv·Aug 10, 2020
- Antigen presentation by tumor-associated macrophages drives tumor-infiltrating T cells from a progenitor exhaustion state to terminal exhaustion
J. Waibl Polania, A. M. Hoyt-Miggelbrink, … P. E. Fecci·bioRxiv·Aug 11, 2023
- Intratumoral cDC1-T Cell Clusters Serve as Sites of Local Costimulation to Enhance CTL-Mediated Tumor Rejection
Catherine B. Carbone, Markus K. Brown, … Christine Moussion·bioRxiv·May 19, 2025
- Intratumoral amino acid insufficiency limits CD8+ T-cell effector function
Yanting Chen, Ya Hui Lin, … Santosha Adipudi Vardhana·bioRxiv·Apr 28, 2025